156 related articles for article (PubMed ID: 38443968)
21. BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity.
Bae SH; Kim JH; Park TH; Lee K; Lee BI; Jang H
Exp Mol Med; 2022 Sep; 54(9):1450-1460. PubMed ID: 36056187
[TBL] [Abstract][Full Text] [Related]
22. Potential Oncogenic Effect of the MERTK-Dependent Apoptotic-Cell Clearance Pathway in Starry-Sky B-Cell Lymphoma.
Farnworth-McHugh S; Barth N; Melville L; Paterson M; Lynch C; Holland P; Dransfield I; Gregory C
Front Immunol; 2020; 11():1759. PubMed ID: 32973744
[TBL] [Abstract][Full Text] [Related]
23. Increased Mer and Axl receptor tyrosine kinase expression on glomeruli in lupus nephritis.
Li S; Guo Q; Zhu H; Li Z; Su Y; Dong B
Clin Rheumatol; 2017 May; 36(5):1063-1070. PubMed ID: 28127639
[TBL] [Abstract][Full Text] [Related]
24. Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma.
Barsoumian HB; Ramapriyan R; Younes AI; Caetano MS; Menon H; Comeaux NI; Cushman TR; Schoenhals JE; Cadena AP; Reilly TP; Chen D; Masrorpour F; Li A; Hong DS; Diab A; Nguyen QN; Glitza I; Ferrarotto R; Chun SG; Cortez MA; Welsh J
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33106386
[TBL] [Abstract][Full Text] [Related]
25. Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal Effects.
Hu Y; Paris S; Barsoumian H; Abana CO; He K; Wasley M; Younes AI; Masrorpour F; Chen D; Yang L; Dunn JD; Zhang J; Gandhi S; Nguyen QN; Cortez MA; Welsh J
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):647-657. PubMed ID: 34242713
[TBL] [Abstract][Full Text] [Related]
26. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression.
Lin J; Xu A; Jin J; Zhang M; Lou J; Qian C; Zhu J; Wang Y; Yang Z; Li X; Yu W; Liu B; Tao H
Oncoimmunology; 2022; 11(1):2024941. PubMed ID: 35036076
[TBL] [Abstract][Full Text] [Related]
27. MERTK Promotes Resistance to Irreversible EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancers Expressing Wild-type
Yan D; Parker RE; Wang X; Frye SV; Earp HS; DeRyckere D; Graham DK
Clin Cancer Res; 2018 Dec; 24(24):6523-6535. PubMed ID: 30194074
[TBL] [Abstract][Full Text] [Related]
28. Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.
Bernsmeier C; Pop OT; Singanayagam A; Triantafyllou E; Patel VC; Weston CJ; Curbishley S; Sadiq F; Vergis N; Khamri W; Bernal W; Auzinger G; Heneghan M; Ma Y; Jassem W; Heaton ND; Adams DH; Quaglia A; Thursz MR; Wendon J; Antoniades CG
Gastroenterology; 2015 Mar; 148(3):603-615.e14. PubMed ID: 25479139
[TBL] [Abstract][Full Text] [Related]
29. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction.
Zizzo G; Hilliard BA; Monestier M; Cohen PL
J Immunol; 2012 Oct; 189(7):3508-20. PubMed ID: 22942426
[TBL] [Abstract][Full Text] [Related]
30. TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment.
Park M; Kuen DS; Park J; Choi M; Kim Y; Roh EC; Choi YJ; Kim YG; Chung Y; Cho SY; Kang KW
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36693679
[TBL] [Abstract][Full Text] [Related]
31. Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma.
Wang S; Zhu L; Li T; Lin X; Zheng Y; Xu D; Guo Y; Zhang Z; Fu Y; Wang H; Wang X; Zou T; Shen X; Zhang L; Lai N; Lu L; Qin L; Dong Q
Cell Rep Med; 2024 Feb; 5(2):101415. PubMed ID: 38382467
[TBL] [Abstract][Full Text] [Related]
32. Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC.
Giroud P; Renaudineau S; Gudefin L; Calcei A; Menguy T; Rozan C; Mizrahi J; Caux C; Duong V; Valladeau-Guilemond J
Front Immunol; 2020; 11():564133. PubMed ID: 33101282
[TBL] [Abstract][Full Text] [Related]
33. Tissue-specific modifier alleles determine
Akalu YT; Mercau ME; Ansems M; Hughes LD; Nevin J; Alberto EJ; Liu XN; He LZ; Alvarado D; Keler T; Kong Y; Philbrick WM; Bosenberg M; Finnemann SC; Iavarone A; Lasorella A; Rothlin CV; Ghosh S
Elife; 2022 Aug; 11():. PubMed ID: 35969037
[TBL] [Abstract][Full Text] [Related]
34. Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles.
Zhang C; Pei J; Kumar D; Sakabe I; Boudreau HE; Gokhale PC; Kasid UN
Methods Mol Biol; 2007; 361():163-85. PubMed ID: 17172711
[TBL] [Abstract][Full Text] [Related]
35. Small Molecule Inhibition of MERTK Is Efficacious in Non-Small Cell Lung Cancer Models Independent of Driver Oncogene Status.
Cummings CT; Zhang W; Davies KD; Kirkpatrick GD; Zhang D; DeRyckere D; Wang X; Frye SV; Earp HS; Graham DK
Mol Cancer Ther; 2015 Sep; 14(9):2014-22. PubMed ID: 26162689
[TBL] [Abstract][Full Text] [Related]
36. MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure.
Triantafyllou E; Pop OT; Possamai LA; Wilhelm A; Liaskou E; Singanayagam A; Bernsmeier C; Khamri W; Petts G; Dargue R; Davies SP; Tickle J; Yuksel M; Patel VC; Abeles RD; Stamataki Z; Curbishley SM; Ma Y; Wilson ID; Coen M; Woollard KJ; Quaglia A; Wendon J; Thursz MR; Adams DH; Weston CJ; Antoniades CG
Gut; 2018 Feb; 67(2):333-347. PubMed ID: 28450389
[TBL] [Abstract][Full Text] [Related]
37. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders.
Gadiyar V; Patel G; Chen J; Vigil D; Ji N; Campbell V; Sharma K; Shi Y; Weiss MM; Birge RB; Davra V
Front Immunol; 2023; 14():1135373. PubMed ID: 37545504
[TBL] [Abstract][Full Text] [Related]
38. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
[TBL] [Abstract][Full Text] [Related]
39. Combination bcl-2 antisense and radiation therapy for nasopharyngeal cancer.
Yip KW; Mocanu JD; Au PY; Sleep GT; Huang D; Busson P; Yeh WC; Gilbert R; O'Sullivan B; Gullane P; Bastianutto C; Liu FF
Clin Cancer Res; 2005 Nov; 11(22):8131-44. PubMed ID: 16299246
[TBL] [Abstract][Full Text] [Related]
40. MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury.
DeBerge M; Yeap XY; Dehn S; Zhang S; Grigoryeva L; Misener S; Procissi D; Zhou X; Lee DC; Muller WA; Luo X; Rothlin C; Tabas I; Thorp EB
Circ Res; 2017 Sep; 121(8):930-940. PubMed ID: 28851810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
